Established in 1966, the International Society of Hypertension (ISH) is committed to promoting and encouraging the advancement of scientific research and knowledge and its application to the prevention and management of heart disease and stroke in hypertension and related cardiovascular diseases around the world.
The Society was registered as a charity in England and Wales in December 2007 and as a registered charitable incorporated organisation in England and Wales in September 2023 (registered charity number: 1204969).
Leading the drive towards the global elimination of raised blood pressure and its complications.
To reduce the global burden of raised blood pressure.
The ISH is dedicated to scientific innovation and advances in medical care in the field of hypertension.
The ISH will endeavour to achieve this philanthropic mission through collaborations, scientific meetings, publications, outreach, and other activities that:
The International Society for Hypertension (ISH) is founded upon the guiding principles of integrity and diversity of all international societies and charitable organisations.
ISH has a Council, whose members are also the Trustees of the Charity. Council members are responsible for furthering the aspirations and activities of the ISH, ensuring its efficient running and helping secure its continuity for the future. The Executive Committee is responsible for the day-to-day management of the Society, has a duty of supervising the affairs of the Society, of making the necessary arrangements for the next ISH Biennial Scientific and General Meetings and other scientific activities, of overseeing the work of all committees and working parties, and for giving final consideration for all nominations for membership. Standing committees exist to carry out specific activities and purposes of the Society. An organogram follows to detail the structure of the current Society, committee and working groups.
The Council is responsible for furthering the aspirations and activities of the ISH, ensuring its efficient running and controlling its property and funds. Council Members are elected members of the Society. A variety of committees, advisory groups, and working groups have been constituted to enable the Council to fulfil its mandate.
The society welcomes applications from trainees, junior and established scientists, clinicians, health care providers, nurses, pharmacists, dietitians, community healthcare workers, members of the public, patients, carers and journalists, all with a common interest in hypertension research.
We have three membership categories including options to join the ISH for free as an Associate Member or a Trainee. There are also reduced and free memberships available for some parts of the world.
ISHF is a symbol of excellence. The election as an International Society of Hypertension Fellow (ISHF) recognises and honours Members of the Society who have distinguished themselves through excellence in clinical practice or research in the field of hypertension.
The ISH Capacity Building Network (CBN) offers career development and networking opportunities for early and mid-career researchers and those from under-represented backgrounds.
The International Society of Hypertension (ISH) has established Regional Advisory Groups (RAGs) for major regions of the world;
Purpose and key areas of responsibility for the RAGs:
To provide ISH representation globally, distil regional issues and encourage and enhance education, good clinical practice and biomedical research in the fields of hypertension and associated cardiovascular diseases.
Our Partners include affiliated national and regional societies of hypertension or cardiac societies, industry (Corporate Members) and other related global organisations.
Companies wishing to become Corporate Members of the ISH should contact the Society.
The ISH Council would like to acknowledge the assistance of the following Corporate Members who are participating in the ISH and therefore helping to promote the advancement of scientific research and knowledge in hypertension and associated cardiovascular diseases.
George Stergiou | Greece | 2024-2026 |
Bryan Williams | UK | 2022-2024 |
Maciej Tomaszewski | UK | 2020-2022 |
Alta Schutte | South Africa / Australia | 2018-2020 |
Neil Poulter | UK | 2016-2018 |
Rhian M Touyz | UK | 2014-2016 |
Ernesto L Schiffrin | Canada | 2012-2014 |
Stephen Harrap | Australia | 2010-2012 |
Tony Heagerty | UK | 2008-2010 |
Lars H Lindholm | Sweden | 2006-2008 |
Michael H Alderman | USA | 2004-2006 |
Lawrence J Beilin | Australia | 2002-2004 |
Albert Mimran | France | 2000-2002 |
Karl-Heinz Rahn | Germany | 1998-2000 |
Jay N Cohn | USA | 1996-1998 |
Kikuo Arakawa | Japan | 1994-1996 |
John Chalmers | Australia | 1992-1994 |
Peter A van Zwieten | Netherlands | 1990-1992 |
Giuseppe Mancia | Italy | 1988-1990 |
John H Laragh | USA | 1986-1988 |
Lennart Hansson | Sweden | 1984-1986 |
Austin E Doyle | Australia | 1982-1984 |
James O Davis | USA | 1980-1982 |
Alberto Zanchetti | Italy | 1978-1980 |
James Ian S Robertson | Italy | 1976-1978 |
Franz Gross | Germany | 1970-1976 |
Irvine H Page | USA | 1966-1970 |
The ISH Awards Committee assists with the selection of awards to individuals, groups or institutions honoured by the Society. This Committee is normally chaired by the Secretary of the Society.
The current version of the ISH Constitution was adopted in September 2022. Separate policy documents contain the specific rules and regulations governing relevant areas including membership, delegation by the Council of its functions to committees and awards and prizes.
View the constitution and policy documents below.
ISH Constitution (last updated September 2022)
ISH Awards and Prizes Regulations (last updated February 2024)
ISH Membership Regulations (last updated December 2023)
ISH endorsement policy
The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.